$1,395 – $3,885

2 Day Workshop: Preparing For The New EU Medical Device Regulations (MDR)

Event Information

Share this event

Date and Time

Location

Location

Burlingame, CA

View Map

Event description

Description

2 Day Workshop: Preparing For The New EU Medical Device Regulations (MDR)

Course has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

"Each attendee will receive 2-Day workshop materials ,Certificate, Complimentary Breakfast , Lunch & High Tea/Coffee provided by WCS"

For more detail please click Here:

Course Description

The new Medical Device Regulations (MDR) were published in the Official Journal of the European Union on May 5, 2017. From that date, manufacturers, suppliers, Notified Bodies, and national competent authorities have a transition period of three years to comply with the new set of rules. Given the large scale of changes, there is great pressure on all actors to analyze the MDR, conduct impact assessments, and implement compliant processes. After May 2020, non-compliance threatens CE-mark certification, access to the European market, or, in the case of Notified Bodies, re-designation.
The European Union released the Medical Devices Regulation (MDR 2017/745/EU) to eventually replace the Medical Devices Directive and Active Implantable Medical Devices Directive. The MDR introduces numerous changes, including a shift from the pre-approval stage to more of a life-cycle approach. It also incorporates a variety of European guidance documents (MEDDEVs) into the regulation and emphasizes the importance of Post-Market Surveillance (PMS), clinical data, clinical evaluations, and Post-Market Clinical Follow-up (PMCF). MDR compliance presents many new challenges to medical device manufacturers. Our in-depth MDR training is designed to help you and your team prepare for these challenges and transition smoothly to the MDR.
This seminar provides a solid understanding of medical device regulation in the EU. It covers the history of medical device regulation in Europe and follows the regulatory requirements throughout the product lifecycle. You will gain a strong foundation of the key elements of the EU directives governing medical devices. These include: Active Implantable Medical Devices Directive (AIMDD) 90/385/EEC, Medical Devices Directive (MDD) 93/42/EEC and In Vitro Diagnostic Devices Directive (IVDD) 98/79/EC in their latest revision, including the 2007/47/EC amendments to AIMDD and MDD. This course examines how devices are classified, and the effect classification has on labeling, registration, marketing and postmarketing requirements. Learn about the new requirements in the Medical Device Regulation (MDR), including those related to quality systems, product classification rules, technical documentation, clinical evaluations, Unique Device Identification (UDI), and postmarket surveillance; and more importantly learn how to plan an efficient transition.

Learning Objectives

• Class I, II and III/In Vitro Diagnostic medical device manufacturers
• Contract medical device manufacturers
• Contract sterilizers
• Repackagers, relabelers, specification developers, reprocessors of single-use devices
• Manufacturers of accessories and components sold directly to the end user
• U.S. manufacturers of "export only" devices
• Distributors
• Importers
• User Facilities (e.g., hospitals, nursing homes)

Course Outline:

Day 1 Schedule

• Introductions and Background
• The objectives of the MDR
• Scope & Definitions
• Placing CE marked product on the market
• EUDAMED and significance of the European Electronic Database
• Notified Bodies
• Classification and Conformity Assessment
• Clinical Evaluation & Investigations
• PMS and Vigilance
• Quality management system requirements in the MDR
• Device classification and conformity assessment routes changes in the MDR
• Technical documentation requirements
• Clinical evaluation process requirements
• UDI and traceability requirements
• Postmarket surveillance and reporting requirements
• Life-cycle review of products linked to risk management and clinical evidence
• Implications for Notified Bodies, and for organizations working with Notified Bodies
• Impact on product portfolios and classification
• The need for improved clinical evidence
• Strengthening of post market surveillance (PMS)

Day 2 Schedule

• How can we prepare to recertify to the MDR?
• Is there an efficient, cost-effective way to train our team on the MDR?
• General obligations of the medical device manufacturer
• Uploading data and maintaining compliance with EUDAMED
• UDI in Europe and how it compares with US FDA UDI requirements and traceability of the supply chain
• Classifying medical devices under the European MDR
• Conformity assessment procedures and the role of Notified Bodies
• Safety and performance requirements
• Navigating standards under 2017/745/EU
• Clinical evaluations and “new rules” on adequacy of clinical data and clinical investigations
• Clinical investigations and Clinical Research Organizations
• Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF)
• Vigilance requirements for Europe
• Economic operator must verify that a previous economic operator has complied with the EU MDR requirements
• EU MDR importation and distribution requirements expand regulatory due diligence from legal manufacturer to importers and distributors
• The role of the Personal Responsible for Regulatory Compliance (PRRC)
• Planning your transition to the MDR
• Interactive Discussions
• Review Regulatory and Compliance Documentation
• Current Trends
Debrief/Adjourn/Wrap-Up

Speaker

David R DillsRegulatory Affairs & Compliance Consultant

David R. Dills,Global Regulatory Affairs & Compliance Consultant currently provides regulatory affairs and compliance consultative services for early-stage and established Class I/II/III device, IVD, biopharmaceutical, cosmetics and nutraceutical manufacturers on the global landscape, and has an accomplished record with more than 27 years of experience in the areas of Regulatory Affairs, Compliance and Quality Systems. He has been previously employed, with increasing responsibilities by device manufacturers and consultancies, including a globally recognized CRO and has worked directly with manufacturers engaged in compliance remediation activities involving consent decrees, CIA’s, warning letters, and customer generated compliance events, conducts QS, regulatory, compliance assessments/audits and FDA Mock Inspections for State of Readiness.


For more detail please click on this below link:
https://worldcomplianceseminars.com/seminardetails/31
Email: support@worldcomplianceseminars.com
Toll Free: 844-267-7299

Share with friends

Date and Time

Location

Burlingame, CA

View Map

Save This Event

Event Saved